AAV-mediated gene transfer of a checkpoint inhibitor in combination with HER2-targeted CAR-NK cells as experimental therapy for glioblastoma

Glioblastoma (GB) is the most common primary brain tumor, which is characterized by low immunogenicity of tumor cells and prevalent immunosuppression in the tumor microenvironment (TME). Targeted local combination immunotherapy is a promising strategy to overcome these obstacles. Here, we evaluated...

Descripción completa

Detalles Bibliográficos
Autores principales: Strecker, M.I., Wlotzka, K., Strassheimer, F., Roller, B., Ludmirski, G., König, S., Röder, J., Opitz, C., Alekseeva, T., Reul, J., Sevenich, L., Tonn, T., Wels, W.S., Steinbach, J.P., Buchholz, C.J., Burger, M.C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9559045/
https://www.ncbi.nlm.nih.gov/pubmed/36249274
http://dx.doi.org/10.1080/2162402X.2022.2127508

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9559045/
https://www.ncbi.nlm.nih.gov/pubmed/36249274
http://dx.doi.org/10.1080/2162402X.2022.2127508

Ejemplares similares